<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03049917</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00000599</org_study_id>
    <secondary_id>323-NJU-TRIAL</secondary_id>
    <nct_id>NCT03049917</nct_id>
  </id_info>
  <brief_title>Financial Incentives to Increase Pediatric HIV Testing</brief_title>
  <acronym>FIT</acronym>
  <official_title>Financial Incentives to Increase Pediatric HIV Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kenyatta National Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Nairobi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether giving small financial incentives will
      motivate parents to test their children for HIV.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a randomized controlled trial (RCT) with 5 arms with equal allocation to
      each arm: no incentive, or one of 4 different levels of financial incentive. We will
      randomize 800 parents with children of unknown status at HIV treatment clinics in Western
      Kenya.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 31, 2017</start_date>
  <completion_date type="Actual">October 1, 2018</completion_date>
  <primary_completion_date type="Actual">October 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HIV testing</measure>
    <time_frame>2 months</time_frame>
    <description>Presents with child(ren) to complete HIV testing at the study clinic within 2 months of recruitment; test results will be recorded in a study questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to HIV testing</measure>
    <time_frame>2 months</time_frame>
    <description>Number of days between randomization and child HIV test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>A priori stratified HIV testing</measure>
    <time_frame>2 months</time_frame>
    <description>HIV testing [primary outcome 1] stratified by caregiver sex, by caregiver age (above and below median), and by having one or more than one eligible child</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A priori stratified time to HIV testing</measure>
    <time_frame>2 months</time_frame>
    <description>Time to HIV testing [primary outcome 1] stratified by caregiver sex, by caregiver age (above and below median), and by having one or more than one eligible child</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characteristics of testers between arms</measure>
    <time_frame>2 months</time_frame>
    <description>Characteristics between index cases who completed testing in each arm: caregiver income, caregiver sex, partnership status, caregiver history of HIV testing and treatment, and number of eligible children in the house; child sex, child history of HIV testing, number of eligible children in the house, and sibling HIV status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness of incentives</measure>
    <time_frame>2 years</time_frame>
    <description>A study questionnaire will be used to collect participant and program costs, and data used to calculate cost effectiveness</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">449</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>No incentive</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No incentive</description>
  </arm_group>
  <arm_group>
    <arm_group_label>KES financial incentive 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Kenyan Shillings conditional cash transfer upon HIV testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>KES financial incentive 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Kenyan Shillings conditional cash transfer upon HIV testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>KES financial incentive 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Kenyan Shillings conditional cash transfer upon HIV testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>KES financial incentive 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Kenyan Shillings conditional cash transfer upon HIV testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Financial incentive</intervention_name>
    <description>Conditional cash transfer upon HIV testing</description>
    <arm_group_label>KES financial incentive 1</arm_group_label>
    <arm_group_label>KES financial incentive 2</arm_group_label>
    <arm_group_label>KES financial incentive 3</arm_group_label>
    <arm_group_label>KES financial incentive 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parent/caregiver receiving HIV care

          -  Parent/caregiver has one or more children &lt;13 years old

          -  Child is HIV exposed (parent/caregiver report or clinic confirmation)

          -  Caregiver reports child's HIV status is unknown

        Exclusion Criteria:

          -  None

               -  The investigators reserve the right to exclude any potential enrollee who is
                  deemed to be at high personal risk, or whose children are at high personal risk,
                  of interpersonal violence, by study participation .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer A Slyker, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Irene N Njugna, MBChB, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington/Kenyatta National Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kisumu County Hospital</name>
      <address>
        <city>Kisumu</city>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kenya</country>
  </location_countries>
  <reference>
    <citation>Wagner AD, Njuguna IN, Neary J, Omondi VO, Otieno VA, Babigumira J, Maleche-Obimbo E, Wamalwa DC, John-Stewart GC, Slyker JA. Financial Incentives to Increase Uptake of Pediatric HIV Testing (FIT): study protocol for a randomised controlled trial in Kenya. BMJ Open. 2018 Oct 3;8(10):e024310. doi: 10.1136/bmjopen-2018-024310.</citation>
    <PMID>30287676</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>February 3, 2017</study_first_submitted>
  <study_first_submitted_qc>February 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2017</study_first_posted>
  <last_update_submitted>January 2, 2020</last_update_submitted>
  <last_update_submitted_qc>January 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Jennifer Slyker</investigator_full_name>
    <investigator_title>Assistant Professor, Department of Global Health</investigator_title>
  </responsible_party>
  <keyword>financial incentive</keyword>
  <keyword>pediatric HIV testing</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Open to collaboration. Please contact the study PIs for requests for data sharing.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>January 2019</ipd_time_frame>
    <ipd_access_criteria>Contact PIs for more info</ipd_access_criteria>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>Current FIT Protocol</doc_id>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://depts.washington.edu/gwach/wp-content/uploads/2012/10/2.18.18-FIT-Protocol_V4.0_clean_.pdf</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

